2018
DOI: 10.1016/j.autrev.2017.11.034
|View full text |Cite
|
Sign up to set email alerts
|

Association between allelic variants of the human glucocorticoid receptor gene and autoimmune diseases: A systematic review and meta-analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 27 publications
0
4
0
Order By: Relevance
“…The human glucocorticoid receptor gene (NR3C1) has been reported to determine the differences and sensitivities of the glucocorticoid response in individuals with autoimmune diseases. 43,44 Based on this, changes in NR3C1 expression may affect the efficacy of glucocorticoid therapy in patients with ITP, which could explain the high NR3C1 expression observed in the remission group in our study. Moreover, the function of the glucocorticoid receptor was found to be regulated by the nuclear protein TPR, which is consistent with the co-upregulation of TPR and NR3C1 observed in our study.…”
Section: Discussionmentioning
confidence: 64%
“…The human glucocorticoid receptor gene (NR3C1) has been reported to determine the differences and sensitivities of the glucocorticoid response in individuals with autoimmune diseases. 43,44 Based on this, changes in NR3C1 expression may affect the efficacy of glucocorticoid therapy in patients with ITP, which could explain the high NR3C1 expression observed in the remission group in our study. Moreover, the function of the glucocorticoid receptor was found to be regulated by the nuclear protein TPR, which is consistent with the co-upregulation of TPR and NR3C1 observed in our study.…”
Section: Discussionmentioning
confidence: 64%
“…The rs6198 SNP has already been studied in many diseases, including autoimmune diseases, but there is a lack of data on GD. A systematic review and meta-analysis by Herrera C. et al [ 51 ] found a protective role for the minor G allele of rs41423247 in autoimmune diseases, especially among Caucasians (OR = 0.78; 95% CI: 0.65, 0.92; p = 0.004). However, the data were insufficient to support evidence that other SNPs, including rs6198, modulated the risk of autoimmune diseases [ 51 ].…”
Section: Discussionmentioning
confidence: 99%
“…A systematic review and meta-analysis by Herrera C. et al [ 51 ] found a protective role for the minor G allele of rs41423247 in autoimmune diseases, especially among Caucasians (OR = 0.78; 95% CI: 0.65, 0.92; p = 0.004). However, the data were insufficient to support evidence that other SNPs, including rs6198, modulated the risk of autoimmune diseases [ 51 ]. Here, we demonstrated that rs6198 is a protective factor for GD.…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, a significantly higher frequency of G allele was described in patients with milder forms of Graves ophthalmopathy (GO) compared to patients with higher disease severity, suggesting that this SNP is associated with a lower risk of severe GO development [38]. A systematic review and meta-analysis evaluating the association between the rs41423247 SNP and autoimmune diseases, showed that the G allele might be even a protective factor for the development of systemic autoimmune disorders among Caucasian patients [39]. Therefore, the association of the G allele and a lower risk of autoimmunity or a milder disease phenotype is compliant with our results, showing that the C allele has a significantly higher frequency among MN patients than controls, which is in line with the autoimmunity in MN.…”
Section: Discussionmentioning
confidence: 99%